Imaging in Pulmonary Hypertension
Author(s) -
Iréne Lang,
Christina Plank,
Roela Sadushi-Koliçi,
Johannes Jakowitsch,
Walter Klepetko,
Gerald Maurer
Publication year - 2010
Publication title -
jacc. cardiovascular imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.79
H-Index - 120
eISSN - 1936-878X
pISSN - 1876-7591
DOI - 10.1016/j.jcmg.2010.09.013
Subject(s) - medicine , pulmonary hypertension , cardiology , ventricle , magnetic resonance imaging , gold standard (test) , scintigraphy , cardiac catheterization , perfusion , right heart failure , radiology , heart failure , right heart catheterization , cardiac magnetic resonance
Pulmonary hypertension is defined as an increase in mean pulmonary arterial pressure ≥25 mm Hg at rest and occurs in a majority of patients with heart failure. Diagnostic imaging targets the right ventricle and the pulmonary vasculature. Although echocardiography is cost-effective for screening and follow-up, right heart catheterization is still mandatory to differentiate pre- from post-capillary disease and to directly measure pressure and flow. An important goal is to rule out chronic thromboembolic pulmonary hypertension. This diagnostic step can be achieved by perfusion scintigraphy, whereas computed tomography and cardiac magnetic resonance have become indispensable ancillary methods for the diagnostic allocation to other World Health Organization subtypes of pulmonary hypertension.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom